Skip to main content
logo
Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Seaport Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '25 Dec '24
Selling, General & Admin
20.9827.35
Research & Development
66.3125.07
Operating Expenses
87.2952.42
Operating Income
-87.29-52.42
Interest Expense (Income)
-11.4-5.54
Other Expense (Income)
-1.78-
Pretax Income
-74.11-46.88
Income Tax
0.77-
Net Income
-74.88-46.88
Free Cash Flow
-78.3-29.74
EBITDA
-87.54-52.2
Depreciation & Amortization
-2.030.21
EBIT
-85.51-52.42
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).